federal_register: 97-4161

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
97-4161 Review of the Adverse Event Reporting System for Postmarketing Surveillance; Public Meeting Notice The Food and Drug Administration (FDA) is announcing a public meeting to provide the pharmaceutical industry and other interested persons with information on the plans, progress, and technical specifications developed under the reengineering of the Center for Drug Evaluation and Research's (CDER's) postmarketing surveillance program. The primary focus of the meeting will be the electronic submission of adverse drug reaction (ADR) reports under the new adverse event reporting system (AERS), which is currently under development as a major component of the reengineering effort. 1997-02-20 1997 2 https://www.federalregister.gov/documents/1997/02/20/97-4161/review-of-the-adverse-event-reporting-system-for-postmarketing-surveillance-public-meeting https://www.govinfo.gov/content/pkg/FR-1997-02-20/pdf/97-4161.pdf Health and Human Services Department 221 The Food and Drug Administration (FDA) is announcing a public meeting to provide the pharmaceutical industry and other interested persons with information on the plans, progress, and technical specifications developed under the reengineering of the...

Links from other tables